Industry News
Novel Drug That Makes Brain Tumors Glow Hot Pink Being Tested
Dec 05, 2011
Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital. "The pain got worse. When we got to the emergency room, I said to Brad 'something is just not right,'" Rek remembers... Read More
Studies Of Patients With Cirrhosis Uncover Limitations In Liver Cancer Screening
Dec 05, 2011
Two studies available in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, have uncovered limitations in screening for primary liver cancer, also known as hepatocellular carcinoma (HCC)... Read More
Tumor-Targeting Compound Points The Way To New Personalized Cancer Treatments
Dec 04, 2011
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients... Read More
MU Researchers Recommend Exercise For Breast Cancer Survivors, Lymphedema Patients
Dec 04, 2011
Lymphedema, a chronic swelling condition common in breast cancer survivors, affects three million people in the U.S. In the past, most people believed that exercise might induce or worsen lymphedema. After reviewing the literature, University of Missouri researchers say the benefits of exercise outweigh the risks for breast cancer survivors and patients with lymphedema... Read More
New Prostate Cancer Blood Test - Developer Wins Award
Dec 03, 2011
The Prostate Cancer Foundation's Young Investigator awards encourage the most innovative minds in cancer research to investigate prostate cancer. The Foundation awards selected researchers with $225,000 over three years to help support their research on prostate cancer treatment and patients... Read More
Matching Patients With Biomarker-Driven Cancer Trials - Genetic Sequencing Might Help
Dec 03, 2011
Cancer researchers are developing a catalog of potential targets for novel treatments while they continue to identify genetic mutations powering different cancer subtypes. Recently, the University of Michigan Comprehensive Cancer Center and Michigan Center for Translational Pathology (MCTP) completed a pilot investigation... Read More
Researchers Find MK1775 Active Against Sarcomas
Dec 03, 2011
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla... Read More
Patient Receives First Prescription For FDA-Approved Brain Tumor Treatment
Dec 03, 2011
The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM. The hospital is one of the first centers in the U.S. to receive training and certification to treat patients with recurrent GBM with a new therapy called Tumor Treating Fields... Read More
Roche's Cobas EGFR Mutation Test For Personalized Treatment Of Non-Small Cell Lung Cancer Receives CE Mark
Dec 03, 2011
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the cobas EGFR Mutation Test is now CE marked for commercial availability in Europe and other countries that recognize CE mark... Read More
Cancer Cells' DNA Repair Disrupted To Increase Radiation Sensitivity
Dec 03, 2011
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research. Researchers would to like see their laboratory findings - published in the journal's Dec... Read More
Previous Page Next Page